Results 91 to 100 of about 3,525 (160)

The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy

, 2018
SummaryThe contact phase has been studied in diabetics and patients with macroangiopathy. Factor XII and high molecular weight kininogen (HMWK) are normal. C1-inhibitor and also α2-macroglobulin are significantly elevated in diabetics with complications,
Fritschi, J, Gattlen, P, Berger, W, Christe, M, Lämmle, B, Duckert, F, Marbet, G A   +6 more
core   +1 more source

Lipoprotein (a) and vascular disease in diabetic patients.

, 1995
In order to assess the potential role of lipoprotein (a) as a risk factor for cardiovascular disease in diabetes mellitus, plasma concentrations were measured in a large group (n = 500) of non-insulin-dependent (NIDDM, n = 355) and insulin-dependent ...
Pometta D, Sirolla C, James RW, Boemi M, Fumelli P, Amadio L   +5 more
core   +1 more source

Implicación del traumatismo en la fisiopatología del pie diabético

Revista Cubana de Medicina Militar
El pie diabético es el resultado de la interacción de factores sistémicos o predisponentes (neuropatía, microangiopatía y macroangiopatía), sobre los que actúan factores desencadenantes y agravantes.
Daniel Rodríguez Gurri
doaj  

A "primitive" catastrophic antiphospholipid syndrome

Haematologica, 1994
A female patient affected by a thrombotic syndrome due to non SLE-related antiphospholipid antibodies (APA), developed a serious, non inflammatory, thrombotic macroangiopathy and uremic-hemolytic syndrome during oral anticoagulant therapy.
P Vivaldi, C Andreotti, C Mazzon, M Pedrazzoli   +3 more
doaj  

Relationship between non-O blood groups and microvascular risk in type 2 diabetes. [PDF]

Diab Vasc Dis Res
Lurquin FO, Petit EL, Oriot P, Ahn SA, Hermans MP.   +4 more
europepmc   +1 more source

Role of Alpha-Defensins 3 and 5 in Diabetic Complications: Associations with Nephropathy and Metabolic Parameters in Type 2 Diabetes. [PDF]

Metabolites
Naydenov Y, Karamfilova V, Assyov Y, Nikolova D, Yordanova S, Kamenov Z, Bogov B, Hristova J, Gateva A.   +8 more
europepmc   +1 more source

Association of glycemic variability with oxidative stress and AGE accumulation in type 2 diabetes. [PDF]

Sci Rep
Ohara M, Takahashi N, Takehana N, Osaka N, Sugita H, Terasaki M, Mori Y, Fukui T, Yamagishi SI.   +8 more
europepmc   +1 more source

The predictive role of protease-activated receptor (PAR-1) polymorphisms and activated microplatelets on the severity of atherosclerosis - preliminary studies. [PDF]

Front Mol Biosci
Jakobsche-Policht U, Bronowicka-Szydełko A, Adamiec R, Bednarska-Chabowska D, Lewandowski Ł, Małecki R, Gostomska-Pampuch K, Adamiec-Mroczek J, Myszka-Kozłowska M, Baczyńska D, Rabczyński M, Kuźnik E, Polański J, Martynowicz H, Dolińska D, Matlak P, Sobczyńska J, Ziomek M, Tota M, Stach W, Madziarska K.   +20 more
europepmc   +1 more source

Diabetic Myonecrosis Presenting as Atraumatic Thigh Pain in a Patient With Poorly Controlled Type 1 Diabetes Mellitus. [PDF]

Spartan Med Res J
Matisse CA, Fatima M, Tuan Mai A, Afzal Cheema H.   +3 more
europepmc   +1 more source

Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study. [PDF]

Lancet Reg Health Eur
Fadini GP, Giaccari A, Broglio F, Nollino L, Fattor B, Anichini R, Meregalli G, Avogaro A, Consoli A, GLIMPLES Study Investigators.   +9 more
europepmc   +1 more source